PTGX

Protagonist Therapeutics Inc

Jun 24 • 04:00PM ET

122.15

+3.19 2.68 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN INCY IONS AXSM MDGL RYTM VKTX ALNY KROS NBIX

| Held by: IJR VTI IWM VB XBI VBK VXF SPSM IJT XSMO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.80	Insider Own	5.13%	Shs Outstand	64.23M	Perf Week	10.40%
Market Cap	7.86B	Forward P/E	-	EPS next Y	-0.91	Insider Trans	-12.71%	Shs Float	61.01M	Perf Month	23.15%
Enterprise Value	7.32B	PEG	-	EPS next Q	2.13	Inst Own	119.98%	Short Float	12.15%	Perf Quarter	21.68%
Income	-114.71M	P/S	106.07	EPS this Y	294.11%	Inst Trans	12.58%	Short Ratio	11.00	Perf Half Y	41.95%
Sales	74.06M	P/B	11.97	EPS next Y	-122.75%	ROA	-15.94%	Short Interest	7.41M	Perf YTD	39.86%
Book/sh	10.21	P/C	14.34	EPS next 5Y	-	ROE	-17.06%	52W High	119.85 1.92%	Perf Year	127.55%
Cash/sh	8.52	P/FCF	-	EPS past 3/5Y	7.63% -1.26%	ROIC	-17.30%	52W Low	49.38 147.37%	Perf 3Y	342.41%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.07% 9.96%	Gross Margin	98.04%	Volatility	3.73% 4.53%	Perf 5Y	184.86%
Dividend TTM	-	EV/Sales	98.81	EPS Y/Y TTM	-302.09%	Oper. Margin	-192.36%	ATR (14)	4.66	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.76	Sales Y/Y TTM	-64.36%	Profit Margin	-154.88%	RSI (14)	72.48	Recom	1.23
Dividend Gr. 3/5Y	- -	Current Ratio	17.76	EPS Q/Q	129.01%	SMA20	15.31%	Beta	1.75	Target Price	119.15
Payout	-	Debt/Eq	0.01	Sales Q/Q	99.03%	SMA50	18.11%	Rel Volume	1.67	Prev Close	118.96
Employees	132	LT Debt/Eq	0.01	Earnings	May 05 AMC	SMA200	38.20%	Avg Volume	673.59K	Price	122.15
IPO	Aug 11, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	109.99% 381.68%	Trades		Volume	1,132,431	Change	2.68%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)